Silexion Therapeutics Corp

NasdaqGM:SLXN Stock Report

Market Cap: US$4.4m

Silexion Therapeutics Corp Company Information

Silexion Therapeutics Corp's employee growth, exchange listings and data sources


Key Information

  • Name: Silexion Therapeutics Corp
  • Ticker: SLXN
  • Exchange: NasdaqGM
  • Founded: 2008
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$4.429m
  • Shares Outstanding: 14.43m
  • Website: https://silexion.com

Location

  • Silexion Therapeutics Corp
  • The Goldyne Savad Institute of Gene Therapy
  • Hadassah Hebrew University Medical Center
  • Jerusalem
  • 9112001
  • Israel


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SLXNNasdaqGM (Nasdaq Global Market)YesNew Ordinary SharesUSUSDApr 2021

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/24 22:27
End of Day Share Price 2024/11/22 00:00
Earnings2013/12/31
Annual Earnings2013/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.